Cargando…
Long-term clinical outcomes of COVID-19 patients treated with imatinib
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853671/ https://www.ncbi.nlm.nih.gov/pubmed/35183270 http://dx.doi.org/10.1016/S2213-2600(22)00052-2 |
_version_ | 1784653280447561728 |
---|---|
author | Duijvelaar, Erik Schippers, Job R Smeele, Patrick J de Raaf, Michiel Alexander Vanhove, Arthur L E M Blok, Siebe G Twisk, Jos W R Noordegraaf, Anton Vonk de Man, Frances S Bogaard, Harm Jan Aman, Jurjan |
author_facet | Duijvelaar, Erik Schippers, Job R Smeele, Patrick J de Raaf, Michiel Alexander Vanhove, Arthur L E M Blok, Siebe G Twisk, Jos W R Noordegraaf, Anton Vonk de Man, Frances S Bogaard, Harm Jan Aman, Jurjan |
author_sort | Duijvelaar, Erik |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8853671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88536712022-02-18 Long-term clinical outcomes of COVID-19 patients treated with imatinib Duijvelaar, Erik Schippers, Job R Smeele, Patrick J de Raaf, Michiel Alexander Vanhove, Arthur L E M Blok, Siebe G Twisk, Jos W R Noordegraaf, Anton Vonk de Man, Frances S Bogaard, Harm Jan Aman, Jurjan Lancet Respir Med Correspondence Elsevier Ltd. 2022-04 2022-02-17 /pmc/articles/PMC8853671/ /pubmed/35183270 http://dx.doi.org/10.1016/S2213-2600(22)00052-2 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Duijvelaar, Erik Schippers, Job R Smeele, Patrick J de Raaf, Michiel Alexander Vanhove, Arthur L E M Blok, Siebe G Twisk, Jos W R Noordegraaf, Anton Vonk de Man, Frances S Bogaard, Harm Jan Aman, Jurjan Long-term clinical outcomes of COVID-19 patients treated with imatinib |
title | Long-term clinical outcomes of COVID-19 patients treated with imatinib |
title_full | Long-term clinical outcomes of COVID-19 patients treated with imatinib |
title_fullStr | Long-term clinical outcomes of COVID-19 patients treated with imatinib |
title_full_unstemmed | Long-term clinical outcomes of COVID-19 patients treated with imatinib |
title_short | Long-term clinical outcomes of COVID-19 patients treated with imatinib |
title_sort | long-term clinical outcomes of covid-19 patients treated with imatinib |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853671/ https://www.ncbi.nlm.nih.gov/pubmed/35183270 http://dx.doi.org/10.1016/S2213-2600(22)00052-2 |
work_keys_str_mv | AT duijvelaarerik longtermclinicaloutcomesofcovid19patientstreatedwithimatinib AT schippersjobr longtermclinicaloutcomesofcovid19patientstreatedwithimatinib AT smeelepatrickj longtermclinicaloutcomesofcovid19patientstreatedwithimatinib AT deraafmichielalexander longtermclinicaloutcomesofcovid19patientstreatedwithimatinib AT vanhovearthurlem longtermclinicaloutcomesofcovid19patientstreatedwithimatinib AT bloksiebeg longtermclinicaloutcomesofcovid19patientstreatedwithimatinib AT longtermclinicaloutcomesofcovid19patientstreatedwithimatinib AT twiskjoswr longtermclinicaloutcomesofcovid19patientstreatedwithimatinib AT noordegraafantonvonk longtermclinicaloutcomesofcovid19patientstreatedwithimatinib AT demanfrancess longtermclinicaloutcomesofcovid19patientstreatedwithimatinib AT bogaardharmjan longtermclinicaloutcomesofcovid19patientstreatedwithimatinib AT amanjurjan longtermclinicaloutcomesofcovid19patientstreatedwithimatinib |